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Background: Stress is a complex phenomenon that may have a negative influence on
health and well-being; consequently, it plays a pivotal role in mental health. Although the
incidence of mental disorders has been continuously rising, development of prevention
and treatment methods has been rather slow. Through the ubiquitous presence of
smartphones and wearable devices, people can monitor stress parameters in everyday
life. However, the reliability and validity of such monitoring are still unsatisfactory.
Methods: The aim of this trial is to find a relationship between psychological stress
and saliva cortisol levels on the one hand and physiological parameters measured
by smartphones in combination with a commercially available wearable device on
the other. Participants include cohorts of individuals with and without a psychiatric
disorder. The study is conducted in two settings: one naturalistic and one a controlled
laboratory environment, combining ecological momentary assessment (EMA) and digital
phenotyping (DP). EMA is used for the assessment of challenging and stressful situations
coincidentally happening during awhole observation week. DP is used during a controlled
stress situation with the Trier Social Stress Test (TSST) as a standardized psychobiological
paradigm. Initially, participants undergo a complete psychological screening and profiling
using a standardized psychometric test battery. EMA uses a smartphone application, and
the participants keep a diary about their daily routine, activities, well-being, sleep, and
difficult and stressful situations they may encounter. DP is conducted through wearable
devices able to continuously monitor physiological parameters (i.e., heart rate, heart
rate variability, skin conductivity, temperature, movement and acceleration). Additionally,
saliva cortisol samples are repeatedly taken. The TSST is conducted with continuous
measurement of the same parameters measured during the EMA.
Discussion: We aim to identify valid and reliable digital biomarkers for stress and stress
reactions. Furthermore, we expect to find a way of early detection of psychological stress
in order to evolve new opportunities for interventions reducing stress. That may allow us
to find new ways of treating and preventing mental disorders.
Trial Registration: The competing ethics committee of the Canton of Zurich,
Switzerland, approved the study protocol V05.1 May 28, 2019 [BASEC: 2019-00814];
the trial was registered at ClinicalTrials.gov [NCT04100213] on September 19, 2019.
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BACKGROUND
Stress is a complex natural phenomenon, broadly defined
as “the non-specific response of the body to any demand”
(1). Oversimplified, this response can be divided into two
components: the physiological reaction on the one hand and
the subjective experience on the other (2, 3). Physiological
stress causes the liberation of hormones (mainly adrenalin and
cortisol) and the activation of the autonomic nervous system
(1–6), resulting in changes in several physiological variables,
including heart rate, heart rate variability, respiratory rate, skin
conductance, and temperature (3–5, 7). The response on the
behavioral level varies greatly; broadly, it may be conceived as a
freeze, flight, fight, fright, or faint response (8).
So far, many studies demonstrate the negative influence of
psychological stress on health and well-being (7) with several
somatic and even some psychiatric disorders etiologically linked
to stress (6, 9). Furthermore, mental disorders are generally
conceived as harmful dysfunctions of psychological coping
and adaptation mechanisms (10). For nearly three decades,
the incidence of mental disorders has been continuously
rising worldwide (11, 12), and this consistently accounts for
a substantial proportion of social costs and the burden of
disease (11, 12). The increment of psychiatric disorders has been
attributed in Western societies to the rise in stress levels. The
development of methods to either prevent psychiatric disorders
or significantly improve their outcome has, by contrast, been
slow (12).
Digital technology and information sciences are expected to
profoundly change the way we understand and approach mental
health (13), for example, the ubiquitous presence of smartphones
(13) and the increasing availability and affordability of wearable
devices capable of measuring bodily functions (14). Digital
phenotyping (DP) seeks to find digital biomarkers, particularly
for cognition, stress, and behavior (13, 15–19), by assessing
smartphone interaction and voice and speech features, together
with monitoring movement and physiological parameters (20,
21). However, from current studies (15, 17), together with
earlier psychological studies (22, 23), it becomes clear that a
proper validation of the users’ individual emotional experience
is essential (13, 16, 24–26).
Through the DP of physiological and psychological stress
reactions, in real-life situations and a controlled laboratory
setting, in a population of healthy participants and patients with
a psychiatric disorder, we expect to find reliable and valid digital
Abbreviations: ANOVA, Analysis of Variance; BNA, Neurocognitive Assessment;
BSI, Brief Symptom Inventory; CEFRL, Common European Framework of
Reference for languages; CGI, Clinical Global Impression Scale; EMA, Ecological
Momentary Assessment; GAF, Global Assessment of Functioning; HAM-A,
Hamilton Anxiety Rating Scale; HAM-D, Hamilton Depression Rating Scale;
HoNOS, Health of the Nation Outcome Scales; HPQ, Hand Preference
Questionnaire; IQ-24, Insecurity Questionnaire; MANOVA,Multivariate Analyses
of Variance; mICF, mini ICF- APP; MINI, Mini International Neuropsychiatric
Interview; MoCa, Montreal Cognitive Assessment; PANSS, Positive and Negative
Syndrome Scale; PSE, Protocol for Sleep Examination; SSQ, Short Stress
Questionnaire; TAQ, Toronto Alexithymia Questionnaire; TSST (-G), Trier Social
Stress Test (for Groups); Y-BOCS: Yale-BrownObsessive Compulsive Scale; YMRS,
Young Mania Rating Scale.
biomarkers. Therefore, we plan to conduct a psychological and
physiological study, combing ecological momentary assessment
(EMA) and a laboratory psychological paradigm to induce stress,
namely the Trier Social Stress Test (TSST) (27).
METHODS/DESIGN
The aim of the present trial is to establish a relationship between
the physiological parameters measured by commercially available
wearable devices and changes in cortisol levels obtained during
everyday difficult and stressful situations and a controlled stress
situation. We expect to establish a valid and reliable DP for stress
and stress reactions as well as for patients with a psychiatric
disorder and otherwise healthy subjects.
Participants
Participants include cohorts of participants with and without
a psychiatric disorder; those with a psychiatric disorder are
further categorized according to diagnosis into internalizing,
externalizing, or psychotic (thought) disorders. To ensure
generalizability of the findings and to minimize confounders,
an overall physically healthy sample is crucial. Another
critical factor is hand preference because it can influence
the measurement and, therefore, reduce generalizability (28);
for convenience, we include only right-handed persons. The
inclusion and exclusion criteria are summarized in Table 1,
and they are determined through the collection of a complete
medical (and psychiatric) history and a medical exam (Figures 1,
2). All participants undergo the same procedures, regarding
TABLE 1 | Inclusion and exclusion criteria for trial participation.
Inclusion criteria
Participants are between 18 and 65 years of age
Participants are competent to give informed consent
Right-handedness as determined by the Hand Preference Questionnaire
(HPQ) (29)
German language proficiency as a native speaker or level B1 according to the
Common European Framework of Reference for Languages (CEFRL) (30)
Diagnosis of a cluster C personality disorder according to ICD-10 (31); or
Diagnosis of a depressive disorder according to ICD-10 (31); or
Diagnosis of schizophrenia or schizoaffective disorder according to ICD-10
(31); or
Without a current psychiatric disorder
Exclusion criteria
Low Intelligence as confirmed by failure to complete regular
compulsory education
Pregnancy or over 2 weeks delay in the menstrual cycle





Current substance use or withdrawal
Any change in medication in the previous week
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FIGURE 1 | Study Outline. The initial and final evaluations (green) include a psychological test battery and the collection of cortisol samples. Well-being and basal
cortisol levels are assessed daily at fixed time frames (only morning and night assessment shown). During the TSST-G (blue) DP, stress and cortisol levels are
conducted. Coincidentally experienced challenging of stressful situations/events (red) are assessed shortly after they occur (shown for illustrative purposes only).
Physiological parameters are continuously assessed through wearable devices.
FIGURE 2 | SPIRIT Study Schedule (EMA, Ecological Momentary Assessment; TSST-G, Trier Social Stress Test for Groups). The bar denotes the different parts of the
intervention (compare Figure 3). ti−2/−1 briefing and tension release exercise previous to the TSST-G; ti1TSST-G Speech; ti2TSST-G Math; ti3/9TSST-G debriefing and
tension release.
psychometric screening and profiling, EMA, DP, and the TSST
for groups.
Psychometric Measurements
All participants (regarding their psychiatric condition) undergo
a full psychological screening and profiling with a standardized
psychometric test battery, including self-administered and
observational instruments. Raters of the following are psychiatry
residents or clinical psychologists. They are trained in specific
workshops on the use and objectives of the measures used in
the study. The workshops follow a standardized schedule, using
case vignettes and video examples. Refresher training sessions are
provided regularly with trainers available for consultation at any
time. The psychometric instruments included in the test battery
are summarized in Table 2.
EMA and DP
The phenomenological assessment usually relies on a first-person
narrative account collected at research or clinical visits. Self-
reports, however, are known to sometimes be inaccurate for
several reasons, for example, that events fade from memory
over time. In contrast, EMA allows the timely record of a
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TABLE 2 | Psychometric measurement instruments included in the Test Battery




The Brief Neurocognitive Assessment (BNA) was
developed as a brief, easily applicable and reliable tool to
evaluate global neurocognition and impairment, primarily
in patients with a diagnosis of schizophrenia (32)
Brief Symptom
Inventory (BSI)
The Brief Symptom Inventory (BSI) (33) is a
self-administered questionnaire assessing psychological




The Clinical Global Impression (CGI) scale was initially
introduced in psychopharmacological trials (34). It is a
brief, easy-to-use, and pragmatic tool for the




The Global Assessment of Functioning (GAF ) is widely
used in psychiatric research. It is a single-item
observer-rated scale of overall functioning on a
continuum from mental health to mental illness (36)
Hamilton Anxiety
Rating (HAM-A)
The Hamilton Anxiety Rating Scale (HAM-A) comprises
14 items and provides an overall measure of anxiety,
including psychological, cognitive, and somatic
symptoms (35, 37). The scale can be used to measure
anxiety in various psychiatric conditions (35)
Hamilton Depression
Scale (HAM-D)
The Hamilton Depression Rating Scale (HAM-D) is a
checklist of 21 items designed to measure the severity of
depression (35, 38). Besides depression, it has also
been used to measure depressive symptoms in other
disorders (35)
Health of the Nation
Outcome Scales
(HoNOS)
The Health of the Nation Outcome Scales (HoNOS) is an
observer-rated scale to assess the severity of a
psychiatric disorder in four dimensions: behavior,
impairment, symptoms, and social problems (39, 40)
Insecurity
Questionnaire (IQ-24)
The Insecurity Questionnaire [German:
Unsicherheitsfragebogen] (IQ-24) is a self-administered
questionnaire with 24 items developed to assess
insecurity (41)
Mini ICF- APP (mICF) The Mini ICF-APP (mICF) is a short observer-rated scale
to assess the level of functioning and capacity. It is easy





The Mini-International Neuropsychiatric Interview (MINI)
(44) is a structured diagnostic interview. It was designed
as a quick but accurate structured psychiatric diagnostic
interview (according to DSM-IV and ICD-10) for clinical
trials and epidemiology studies
Montreal Cognitive
Assessment (MoCA)
The Montreal Cognitive Assessment (MoCA) (45, 46) is a
brief cognitive screening tool to detect mild cognitive
impairment in patients performing in the normal range on




The Positive and Negative Syndrome Scale (PANSS) is a
semistructured interview designed to measure the
severity of psychopathology in patients with a psychotic
disorder: mainly schizophrenia and schizoaffective
disorder (35, 47). The PANSS measures symptoms in
three domains: positive, negative, and general symptoms
Protocol for Sleep
Examination (PSE)
The Protocol for Sleep Examination [German:
Abend/Morgenprotokolle für die Schlafuntersuchung]
(PSE) was developed to assess the subjective dimension
of sleep, daily activities, and distress. It is divided into
morning and night (bedtime) sections (48)
(Continued)




The Short Stress Questionnaire [German:
Kurzfragebogen zur aktuellen Beanspruchung] (SSQ)
was developed to assess subjective levels of tension or




The Toronto Alexithymia Questionnaire (TAQ) (50, 51)
was developed to assess difficulties identifying subjective
emotional feelings, distinguishing between feelings and
the bodily sensations of emotional arousal and difficulty




The Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
was developed to measure the severity of
obsessive-compulsive symptoms; these are rated in
terms of time spent on such activities, interference with
functioning, distress, resistance, and control (35, 53)
Young Mania Rating
Scale (YMRS)
The Young Mania Rating Scale (YMRS) is an
observer-rated checklist, measuring manic symptoms to
quantify the severity and the effect of treatment (35, 54).
It includes the core symptoms of mania occurring in both
mild and severe illness.
person’s experience and behavior in the natural environment,
thus, increasing the validity and allowing the inference of factors
influencing behavior and experience. EMA is a long-known
methodology in psychological and anthropological research,
usually with the use of dairies or logbooks. The appearance of
smartphones and wearable devices facilitates the implementation
of EMA studies (55, 56).
EMA is conducted over a whole week using a custom
smartphone application and two wearable devices. Through
the smartphone application, participants are able to evaluate
their daily activities and sleep. In addition, the application
prompts the participants once or twice a day about their
current activity. Participants are able to log any stressful
and challenging situation. Participants have to answer a
short questionnaire regarding their current activity, well-
being, and stress level (see Figures 1, 2). Through two
commercially wearable devices (Vívosmart R© wristband and
Everion R© armband), several physiological parameters are
continuously monitored and recorded, including heart rate,
skin conductance, temperature, movement, and acceleration
(see Table 3). We included two devices in order to allow for
comparison and generalizability of the results, especially taking
into account possible flaws in the use and the measurement
quality of the devices (57).
Cortisol secretion follows a circadian rhythm, usually with a
peak in the morning and slowly declining throughout the day
with variations from day to day and individual to individual
(58). Therefore, for proper validation and interpretation,
regular measurements of cortisol levels are necessary (59, 60).
Participants collect a saliva sample four times a day (morning,
midday, afternoon, and night); after experiencing a difficult or
stressful situation and at random once or twice a day. Saliva
samples are picked up and sent once a day (at night) to the
laboratory for the quantification of cortisol levels, and after
analysis, samples are destroyed.
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TABLE 3 | Digital parameters for Ecological Momentary Assessment (EMA) and
Digital Phenotyping (DP).
Parameter Smartphone Everion® Vívosmart®
Heart rate X X
Heart rate variability X X
Blood pulse wave X
Respiratory rate X
Oxygenation X
Skin blood perfusion X
Skin temperature X
Electrodermal activity X




Trier Social Stress Test for Groups (TSST-G)
The TSST is an extensively used and well-validated psychological
paradigm to induce psychobiological stress in laboratory settings
(61–64) with a significant association with an acute stress
response in real life (62, 65, 66). The TSST has been modified
in order to be conducted in groups; in our current study, we
include three to five participants (from the same diagnostic
group), using TSTT-G procedures analogous to previous studies
(67–69). The TSST-G consists of three phases: a briefing, the
psychological test itself, and a debriefing. The phases last 40,
20, and 60min, respectively (Figures 2, 3). An experienced
psychotherapist conducts the briefing and debriefing of the TSST-
G. The TSST-G itself is conducted by personnel unknown to the
participants. During the TSST-G, saliva samples are obtained at
regular intervals and cortisol levels measured.
Each participant undergoes an individual briefing phase.
Participants are required to prepare a speech for a job application.
After a few minutes, participants are accompanied into the test
room and are seated next to each other, separated by partitions in
order to avoid eye contact. They are told that an expert committee
will conduct an analysis of their performance and that they will
be videorecorded (no actual recording is performed) for further
analysis. The participants present their speech (2–3min each) in
a previously set random order. Next, the participants conduct
a subtraction task (for 2min) as quickly and as accurately as
possible. If participants make a mistake, they are asked to start
over again. The order of participation once again is random.
Once the last participant has completed the task, the committee
leaves the room. Participants are accompanied back to the
preparation room, where they are debriefed and may engage in
any relaxing activity for 60 min.
Sample Size Calculation and Statistical
Analysis
Previous research has consistently shown that the TSST
significantly increases the cortisol levels with moderate effect
sizes regarding baseline (63). Therefore, we expect a low to
moderate effect size in cortisol through the TSST-G in our study.
We calculate our required sample size using G∗Power 3.1 (70)
(ANOVA: repeated measures, within and between factors; effect
size f = 0.4; α = 0.05; power = 0.8; number of groups = 4,
number of measures = 9, nonsphericity correction = 0.125).
Based on that calculation, at least 24 participants per group
are required to detect moderate-sized differences: to improve
capacity, we include at least 30 participants in each group. Only
data sets of participants who complete the intervention are
considered (completed TSST-G and at least 70% completion of
the EMA); therefore, recruitment continues until the number
of participants for each group is reached. Already enrolled
participants are able to complete the study.
The primary analysis is conducted with complete cases only;
dropouts are replaced by recruiting new subjects. Secondary
analysis includes incomplete cases and dropouts. If a participant
withdraws from the study, his or her data is anonymized and
his or her name is deleted permanently from all study records.
Unless otherwise stated, his or her remaining data is used in
the secondary analysis. Data analysis does not pursue hypothesis
testing; through the statistic scrutiny of the data, we aspire to gain
a better understanding of the possibilities offered by wearable
devices for the assessment of stress and stress reactions and
finding digital biomarkers. Accordingly, the findings of the study
serve for the formulation of hypothesis and hypothesis testing in
future studies.
The demographic and clinical characteristics of the sample
are compared at baseline using an ANOVA, excluding gender,
which is analyzed using the chi-square test. Repeated-measures
multivariate analyses of variance (MANOVAs) are used to
assess changes in symptomatology, functionality, cognition,
and physiological parameters. To infer differences in stress
reactions according to the subjective experience and clinical
characteristics, we use a multivariate regression analysis as well
as time series analysis. To avoid inflation of type II errors, we
apply a Bonferroni correction for multiple comparisons. The
significance threshold is set at 0.05. Cohen’s d is calculated to
determine the effect size (71). Multiple and logistic analyses as
well as time series analysis is performed. Due to the complexity
of the data, with a large number of variables and potential
confounders, a machine learning algorithm is used to detect
complex relationships between the stress, psychopathology, and
physiological measures (72).
For each wearable device, machine learning is conducted
stepwise, using a supervised learning approach at first and a deep
learning approach at last. For analysis, three separate data sets
are created. The first data set comprises the measures collected
during the TSST-G with the speech and math as stress events
and the briefing and debriefing as relaxing events. This data
set is subdivided into two sets: one for training the model and
one for testing. One stress and one relaxing event are randomly
assigned to either one of the data sets. The second data set
consists of the three full-day measurements selected at random:
two from the days previous and one from the days after the TSST-
G. The second data set is used for the deep learning algorithm
for the detection of stress and relaxation. The third and final
data set comprises the remaining days: two previous and one
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FIGURE 3 | Outline for the Trier Social Stress Test (for Groups). Physiological parameters are continuously monitored. At each time point, a psychological stress
response assessment takes place and a saliva cortisol sample is collected.
after the TSST-G. This data set will be used for testing the
obtained models.
Quality of Data, Missing Data
The design of our trial, with the preparation of the probands
and instruments, allows us to ensure that measurements obtained
during the TSST-G have high quality with a low artifact rate. Due
to the complexity and duration of the remaining intervention, we
cannot rule out that all the measurements obtained will reach a
high-quality threshold. The use of a device (Everion R©) with a
high measurement quality as well as its placement (57) should
increase the quality of the measurements. Missing measurements
and artifacts from the digital devices are not replaced. Missing
items in the different psychometric instruments are replaced
according to the rules and conventions for each instrument.
TRIAL STATUS
The competing ethics committee of the Canton of Zurich,
Switzerland, approved the study protocol V05.1- May 28,
2019 [BASEC: 2019-00814]; the trial was registered at
ClinicalTrials.gov [NCT04100213] on September 19, 2019.
Recruitment starts in Fall/Winter 2020. We expect to recruit the
whole sample in 9 to 12 months from the first enrollment.
DISCUSSION
Stress is a known risk factor for several, if not all, psychiatric
disorders. However, the perception and reaction to stress
show considerable variability among the general population
and even more among those suffering from a psychiatric
disorder. Healthy subjects are more or less consciously aware
of stress and potentially stressful situations and, therefore,
able to adjust and modify their behaviors in order to master
life’s challenges. Patients with a psychiatric disorder, conversely,
have a disrupted perception, awareness, and reaction to stress
(2, 73, 74), hampering them in adapting and coping with
everyday demands. Stress has, therefore, become amajor target of
lifestyle and well-being and psychiatric prevention and treatment
research with several interventions focusing on stress awareness
and management.
The use of smartphones and wearable devices nowadays
is ubiquitous with a significant increase in their application
to monitor psychological well-being and stress. Uncountable
digital services are claiming to appraise and improve physical
and psychological well-being (26, 75). However, despite gaining
popularity, their use remains controversial. Users frequently
experience deception (76, 77), generally due to privacy and
confidentiality issues (25, 76, 78, 79) but also inaccurate feedback
or even dangerous advice (25, 26, 79).
There is still a lack of guidance in the use of such devices in
general and in psychiatry in particular with guidelines and legal
regulations that are still emerging (61, 80). From the available
services, only a tiny fraction has been validated adequately in
controlled studies (24, 26, 81). Persons with a psychiatric disorder
are under-represented in current studies, reducing the use and
applicability of such devices in psychiatric settings. Their reckless
use may be detrimental, dangerous, or even harmful (81, 82).
From current digital trials (15, 17) and earlier psychological
studies (22, 23), it is clear that proper validation and fitting to the
users’ individual emotional experience is required (13, 16, 24–
26). We consider it essential to assess the individual stress and
stress reactions in everyday situations and a controlled laboratory
setting. The TSST (27) is an extensively used and well-validated
psychological paradigm to induce psychobiological stress (61–64)
with a significant association with acute stress response in real life
(62, 65, 66).
In order to establish valid and reliable digital biomarkers, the
study population is crucial (16, 20). Psychiatric diagnoses have
overlapping symptoms and high psychiatric comorbidity (74, 83),
making it challenging to form homogeneous groups. Therefore,
in our study, we aim to establish a complete psychological
profile (beyond individual diagnoses) of the participants with
a transdiagnostic test battery, including the assessment of
threshold and subthreshold psychiatric symptoms. Likewise, we
assess their psychosocial functioning, well-being, level of stress,
and coping with the challenges of daily life. Cortisol release shows
variations between and within individuals (58).
The regular sampling of cortisol in saliva during a whole
week allows us to establish the cortisol secretion profile
for each participant; the TSST-G allows us to establish the
cortisol release during a standardized, controlled, and validated
psychobiological stress paradigm, therefore, giving us a “fisheye
perspective” on stress and stress reaction. We expect that day-
to-day situations experienced as challenging and stressful enact a
similar cortisol release and physiological response as the TSST-G.
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We anticipate that well-being and certain psychopathological
states modify the individual’s self-awareness and, therefore, the
perception and reaction of challenging and stressful situations.
The combination of psychopathological profiling, assessment
of the subjective stress experience, physiological monitoring,
and psychological observation during everyday life and under
controlled and standardized laboratory conditions, however,
provides a panoramic view, which, in turn, allows us to determine
reliable and valid digital biomarkers.
The digital biomarkers we expect to find have the potential
to facilitate self-monitoring of stress as well to serve as part
of our diagnostic and therapeutic instruments. The use of both
devices (high-quality and over-the-counter) allows inferring the
suitability of this approach for daily use. The results obtained
from this study serve for further hypothesis formulation and
testing. Taking into account the complexity and dynamics in
the field of digital technologies, the next step for testing and
validating our results should take place in the frame of a citizen
science project (84), simultaneously allowing the dissemination
and improvement of the results of this study.
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